- Home
- AVD vs FENC Comparison
AVD vs FENC Comparison
Compare AVD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVD | FENC |
|---|---|---|
| Founded | 1969 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.6M | 258.5M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | AVD | FENC |
|---|---|---|
| Price | $3.92 | $7.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 192.0K | 166.4K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $530,073,000.00 | $38,790,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.54 | $75.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.28 | $4.68 |
| 52 Week High | $6.33 | $9.92 |
Technical Indicators
Market Signals| Indicator | AVD | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 33.72 | 44.14 |
| Support Level | $4.12 | $7.35 |
| Resistance Level | $4.48 | $8.00 |
| Average True Range (ATR) | 0.19 | 0.33 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 1.24 | 22.78 |
Price Performance
Historical ComparisonAbout AVD American Vanguard Corporation ($0.10 Par Value)
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.